Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
Evaluate the incidence of acute rejection at 12 months after transplantation in subjects
receiving induction therapy with cyclosporine microemulsion (CsA) and Rapamune followed by
CsA dose reduction (Phase I) with subjects receiving induction therapy with CsA and Rapamune
followed by CsA discontinuation (Phase II) in Chinese de novo renal allograft recipients.